Abstract

The National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada (PHAC) with ongoing and timely medical, scientific, and public health advice relating to immunization.

NACI generally issues guidance on immunization programs and research priorities for immunizing agents that have been authorized by Health Canada. However, in this exceptional circumstance of the coronavirus disease (COVID-19) pandemic, PHAC has requested rapid guidance from NACI on research priorities for COVID-19 vaccine candidates to support public health decision-making.

PHAC acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. NACI members and liaison members conduct themselves within the context of PHAC’s Policy on Conflict of Interest, including yearly declaration of potential conflict of interest.

Recommendation Americas Canada